Return On Assets of Inhibitor Therapeutics, Inc. from 30 Jun 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Inhibitor Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2014 to 30 Sep 2025.
  • Inhibitor Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -80%, a 96% decline year-over-year.
  • Inhibitor Therapeutics, Inc. annual Return On Assets for 2024 was -49%, a 61% decline from 2023.
  • Inhibitor Therapeutics, Inc. annual Return On Assets for 2023 was -31%, a 108% decline from 2022.
  • Inhibitor Therapeutics, Inc. annual Return On Assets for 2022 was 399%.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Inhibitor Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -80% -39% -96% 01 Jul 2025 30 Sep 2025
Q2 2025 -67% -31% -86% 01 Apr 2025 30 Jun 2025
Q1 2025 -55% -20% -59% 01 Jan 2025 31 Mar 2025
Q4 2024 -49% -19% -61% 01 Oct 2024 31 Dec 2024
Q3 2024 -41% -139% -141% 01 Jul 2024 30 Sep 2024
Q2 2024 -36% -170% -127% 01 Apr 2024 30 Jun 2024
Q1 2024 -35% -238% -117% 01 Jan 2024 31 Mar 2024
Q4 2023 -31% -430% -108% 01 Oct 2023 31 Dec 2023
Q3 2023 99% +618% 01 Jul 2023 30 Sep 2023
Q2 2023 134% +582% 01 Apr 2023 30 Jun 2023
Q1 2023 204% +513% 01 Jan 2023 31 Mar 2023
Q4 2022 399% +679% 01 Oct 2022 31 Dec 2022
Q3 2022 -519% -262% -102% 01 Jul 2022 30 Sep 2022
Q2 2022 -448% -15% -3.4% 01 Apr 2022 30 Jun 2022
Q1 2022 -309% +234% +43% 01 Jan 2022 31 Mar 2022
Q4 2021 -280% +218% +44% 01 Oct 2021 31 Dec 2021
Q3 2021 -257% +148% +36% 01 Jul 2021 30 Sep 2021
Q2 2021 -433% -165% -61% 01 Apr 2021 30 Jun 2021
Q1 2021 -543% -354% -186% 01 Jan 2021 31 Mar 2021
Q4 2020 -498% -309% -163% 01 Oct 2020 31 Dec 2020
Q3 2020 -405% -181% -80% 01 Jul 2020 30 Sep 2020
Q2 2020 -269% -26% -11% 01 Apr 2020 30 Jun 2020
Q1 2020 -190% +113% +37% 01 Jan 2020 31 Mar 2020
Q4 2019 -190% +103% +35% 01 Oct 2019 31 Dec 2019
Q3 2019 -224% +62% +22% 01 Jul 2019 30 Sep 2019
Q2 2019 -243% +35% +12% 01 Apr 2019 30 Jun 2019
Q1 2019 -303% -76% -33% 01 Jan 2019 31 Mar 2019
Q4 2018 -292% +3% +1% 01 Oct 2018 31 Dec 2018
Q3 2018 -286% -80% -39% 01 Jul 2018 30 Sep 2018
Q2 2018 -277% -78% -39% 01 Apr 2018 30 Jun 2018
Q1 2018 -227% -45% -24% 01 Jan 2018 31 Mar 2018
Q4 2017 -295% -126% -74% 01 Oct 2017 31 Dec 2017
Q3 2017 -206% +3.4% +1.6% 01 Jul 2017 30 Sep 2017
Q2 2017 -199% +46% +19% 01 Apr 2017 30 Jun 2017
Q1 2017 -182% +152% +46% 01 Jan 2017 31 Mar 2017
Q4 2016 -169% +163% +49% 01 Oct 2016 31 Dec 2016
Q3 2016 -210% +143% +41% 01 Jul 2016 30 Sep 2016
Q2 2016 -245% +174% +41% 01 Apr 2016 30 Jun 2016
Q1 2016 -335% +1096% +77% 01 Jan 2016 31 Mar 2016
Q4 2015 -332% +996% +75% 01 Oct 2015 31 Dec 2015
Q3 2015 -352% +1417% +80% 01 Jul 2015 30 Sep 2015
Q2 2015 -419% +4368% +91% 01 Apr 2015 30 Jun 2015
Q1 2015 -1431% 01 Jan 2015 31 Mar 2015
Q4 2014 -1328% 01 Oct 2014 31 Dec 2014
Q3 2014 -1769% 01 Jul 2014 30 Sep 2014
Q2 2014 -4786% 01 Apr 2014 30 Jun 2014

Inhibitor Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -49% -19% -61% 01 Jan 2024 31 Dec 2024
2023 -31% -430% -108% 01 Jan 2023 31 Dec 2023
2022 399% +679% 01 Jan 2022 31 Dec 2022
2021 -280% +218% +44% 01 Jan 2021 31 Dec 2021
2020 -498% -309% -163% 01 Jan 2020 31 Dec 2020
2019 -190% +103% +35% 01 Jan 2019 31 Dec 2019
2018 -292% +3% +1% 01 Jan 2018 31 Dec 2018
2017 -295% -126% -74% 01 Jan 2017 31 Dec 2017
2016 -169% +163% +49% 01 Jan 2016 31 Dec 2016
2015 -332% +996% +75% 01 Jan 2015 31 Dec 2015
2014 -1328% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.